14293-04-0

Basic information

• Product Name: 5-hydroxyimino-5-phenylpentanoic acid
• Synonyms: 5-hydroxyimino-5-phenylpentanoic acid
• CAS NO: 14293-04-0
• Molecular Weight: 207.229
• Mol File: 14293-04-0.mol

Chemical Properties

• CAS DataBase Reference: 5-hydroxyimino-5-phenylpentanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 5-hydroxyimino-5-phenylpentanoic acid(14293-04-0)
• EPA Substance Registry System: 5-hydroxyimino-5-phenylpentanoic acid(14293-04-0)

Safety Data

• Hazardous Substances Data: 14293-04-0(Hazardous Substances Data)

Upstream product

• 1501-05-9 5-oxo-5-phenylvaleric acid 

Downstream Products

• 91247-40-4 5-amino-5-phenylpentanoic acid 
• 1232366-40-3 4,5-dihydro-3-phenyl-7H-1,2-oxazepin-7-one 

Relevant articles and documents

An Iridium-Catalyzed Reductive Approach to Nitrones from N-Hydroxyamides

An Ir-catalyzed reductive formation of functionalized nitrones from N-hydroxyamides was reported. The reaction took place through two types of iridium-catalyzed reactions including dehydrosilylation and hydrosilylation. The method showed high chemoselectivity in the presence of sensitive functional groups, such as methyl esters, and was successfully applied to the synthesis of cyclic and macrocyclic nitrones, which are known to be challenging compounds to access by conventional methods. 1H NMR studies strongly supported generation of an N-siloxyamide and an N,O-acetal as the actual intermediates.

Structures of 4-Hydroxyimino-4-phenylbutanoic Acid, C10H11NO3 (I), and 5-Hydroxyimino-5-phenylpentanoic Acid, C11H13NO3 (II), at 223 K

Infinite polar chains of molecules with strong intermolecular hydrogen bonds (O-H...N and O-H...O) are observed between carboxyl and oxime groups N...O 2.697(1) and O...O 2.784(1) Angstroem for (I), and 2.690(2) and 2.744(2) Angstroem for (II), respectiv

Reductive approach to nitrones from N-Siloxyamides and N-Hydroxyamides

This article describes the full details of our reductive approach to nitrones from amides. Reduction of N-siloxyamides with the Schwartz reagent [Cp2ZrHCl], followed by addition of an acid provided functionalized nitrones. The developed conditi

Cyclic O-acyloximes as novel photolatent bases

Cyclic O-acyloximes were prepared as novel photolatent bases with good photoreactivity and thermal stability. They were transformed into cyclic imines on irradiation at 254 nm and showed higher crosslinking ability for poly(glycidyl methacrylate) compared

Lactam and cyclic urea derivatives useful as alpha 1a adrenoceptor antagonists

Lactam and cyclic urea derivatives and their pharmaceutically acceptable salts are disclosed. The synthesis of these compounds and their use as alpha 1aadrenergic receptor antagonists is also described. One application of these compounds is in the treatment of benign prostatic hyperplasia. These compounds are typically selective in their ability to relax smooth muscle tissue enriched in the alpha 1areceptor subtype without at the same time inducing hypotension. One such tissue is found surrounding the urethral lining. Therefore, one utility of the instant compounds is to provide acute relief to males suffering from benign prostatic hyperplasia, by permitting less hindered urine flow. Another utility of the instant compounds is provided by combination with a human 5-alpha reductase inhibitory compound, such that both acute and chronic relief from the effects of benign prostatic hyperplasia can be achieved.